Author

Polina Brangel

Observed name: Brangel, Polina

Institutions: World Health Organization, Coalition for Epidemic Preparedness Innovations

Observed institutions: London Centre for Nanotechnology, Coalition for Epidemic Preparedness Innovations, World Health Organization, Coalition for Epidemic Preparedness Innovations, University College London, Imperial College London

ORCID: 0000-0002-9295-4842

Observed ORCID: 0000-0002-9295-4842

OpenAlex ID: A5035570605

A Serological Point-of-Care Test for the Detection of IgG Antibodies against Ebola Virus in Human Survivors

2018 · Polina Brangel, Ariel Sobarzo, et al. · ACS Nano · 203

Rapid diagnostic test: a critical need for outbreak preparedness and response for high priority pathogens

2024 · Solomon Abebe Yimer, Birgitte Boonstra Booij, et al. · BMJ Global Health · 52

The Development and Validation of a Novel Nanobody-Based Competitive ELISA for the Detection of Foot and Mouth Disease 3ABC Antibodies in Cattle

2018 · Sigal Gelkop, Ariel Sobarzo, et al. · Frontiers in Veterinary Science · 41

Sensitivity and specificity of diagnostic tests for Lassa fever: a systematic review

2019 · Noah Fongwen Takah, Polina Brangel, et al. · BMC Infectious Diseases · 36

A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories

2024 · Polina Brangel, Sina Tureli, et al. · Viruses · 7

Long-term Sudan Virus Ebola Survivors Maintain Multiple Antiviral Defense Mechanisms

2023 · Ariel Sobarzo, Yves Moné, et al. · The Journal of Infectious Diseases · 7

Evaluating the use of the first WHO International Standard for anti-SARS-CoV-2 immunoglobulin to harmonise the readouts between commercial SARS-CoV-2 binding antibody tests: the HARMONY multicentre calibration study

2026 · Amanda Semper, Peter Rigsby, et al. · The Lancet Microbe · 2

Searching for immune correlates in Lassa vaccine development – workshop report

2026 · Trevor Brasel, Polina Brangel, et al. · npj Vaccines · 1

Nucleoprotein and glycoprotein based serological assays for detection of Marburg virus infections

2026 · James Kagame, Markus H. Kainulainen, et al. · EBioMedicine · 1

Marburg virus persistence and clinical complications among recovered persons in Rwanda: a longitudinal study protocol

2026 · JCS Ngabonziza, Eric Seruyange, et al. · BMJ Open

CEPI Workshop Report: Applying Disease X Vaccine Library and Knowledge Base Approaches to Severe Fever with Thrombocytopenia Syndrome (SFTS)

2026 · Mitsutaka Kitano, Byoung-Shik Shim, et al. · Vaccines

Beyond the cloud: a resilient sovereign edge architecture for vaccine independence in the Global South

2026 · Philippe-Alexandre Gilbert, Newton Wahome, et al. · Vaccine Insights

Speaking the Same Language: Use of the 1 st WHO International SARS-CoV-2 Immunoglobulin Standard to Achieve Comparability Between Commercial SARS-CoV-2 Binding Antibody Assay Readouts

2022 · Amanda Semper, Peter Rigsby, et al. · SSRN Electronic Journal

Comprehensive Profiling of Immune Responses in MARV Survivors Demonstrates Robust Th1-Skewing with Short-Lived Neutralizing Antibody Responses

2017 · Spencer W. Stonier, Andrew S. Herbert, et al.

Development of nanoparticle-based biosensing for molecular diagnostics

2016 · Brangel, Polina

The development of an electrochemical lateral flow immunosensor for the detection of native autoimmune response to GIPC1

2011 · Brangel, Polina, Marks, Robert S., et al. · HAL (Le Centre pour la Communication Scientifique Directe)

Works count: 19

Citation count: 350

H-index: 6

I10-index: 4